Mona Mashayekhi Archive — Page 1 of 1

Close-up of a person using a glucometer to measure blood glucose from a fingertip, with a lancing device and small container nearby.
October 5, 2026

Human trial: Popular diabetes drug shown to lower inflammation, which may protect the heart

Individuals taking the drug saw a significant drop in inflammatory cell clumps within just two weeks, and the reduction grew even stronger by week 12.

By Jill Clendening
David Orth and Linda D’Errico pose together in their home pottery studio, surrounded by shelves of ceramic vessels and pottery tools, with several glazed pieces on the worktable.
July 3, 2024

Couple’s legacy of giving results in transformative change in endocrinology at Vanderbilt

“As I worked at Vanderbilt, I became so attached to the division, and when I had the ability to do it, I wanted to give back.”

By Jill Clendening
Person using a handheld blood glucose meter with a test strip on a fingertip; a lancing device and small container sit nearby.
January 4, 2024

Study shows liraglutide results in increased insulin sensitivity independent of weight loss

By Jill Clendening
Grid of ten professional headshots arranged in two rows, labeled Brittain, Self, Shibao, Wilson, Casey, Haake, Terker, Wanjalla, Bock, and Mashayekhi.
February 9, 2023

American Society for Clinical Investigation honors 10 Vanderbilt physicians

By Bill Snyder
Stylized close-up of dark molecular ball-and-stick structures against a bright blue-white background.
March 24, 2022

Reducing obesity-related inflammation

A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation.

By Lindsey Guerin
Insulin in vials
February 18, 2021

Gene variant and glucose metabolism

Genetic variation that impacts glucose- and insulin-related signaling affects responses to type 2 diabetes treatments and warrants further study.

By Leigh MacMillan